These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The scandal of device regulation in the UK. Williams N Lancet; 2012 May; 379(9828):1789-90. PubMed ID: 22579318 [No Abstract] [Full Text] [Related]
3. Medical device preemption after Medtronic, Inc. v. Lohr. Neraas MB Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731 [No Abstract] [Full Text] [Related]
4. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr. Jarcho DG Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730 [No Abstract] [Full Text] [Related]
5. The scandal of device regulation in the UK. Lewi H; Frame JD Lancet; 2012 May; 379(9828):1790. PubMed ID: 22579320 [No Abstract] [Full Text] [Related]
6. Who should protect the public? The Supreme Court and medical device regulation. Korobkin R N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010 [No Abstract] [Full Text] [Related]
7. Achieving medical device safety in an era of globalization. Meritz JK; White TL Food Drug Law J; 2008; 63(3):647-55. PubMed ID: 19031664 [No Abstract] [Full Text] [Related]
8. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
9. How medical devices are regulated in the UK. Drug Ther Bull; 2010 Jul; 48(7):82-4. PubMed ID: 20631197 [TBL] [Abstract][Full Text] [Related]
10. Registration and regulation of medical devices used in diabetes in Europe: need for radical reform. Boulton AJ Lancet Diabetes Endocrinol; 2013 Dec; 1(4):270-2. PubMed ID: 24622409 [No Abstract] [Full Text] [Related]
11. Postmarket surveillance. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947 [TBL] [Abstract][Full Text] [Related]
12. CE marking and medical device directives. Shedden DJ Commun Dis Public Health; 1999 Jan; 2(1):73. PubMed ID: 10462905 [No Abstract] [Full Text] [Related]
13. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act. Carrier MK Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729 [No Abstract] [Full Text] [Related]
14. The Canadian perspective: trends in drug and medical device class actions in Canada. Vernon W Food Drug Law J; 2006; 61(3):569-76. PubMed ID: 16989040 [No Abstract] [Full Text] [Related]
15. Medical-device safety and the FDA. Schultz DG N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278 [No Abstract] [Full Text] [Related]
16. Brain-Computer Interface devices: risks and Canadian regulations. Alpert S Account Res; 2008; 15(2):63-86. PubMed ID: 18593098 [TBL] [Abstract][Full Text] [Related]
17. Switzerland: one year's experience with new regulations and a new agency. Voelksen R Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697 [TBL] [Abstract][Full Text] [Related]
18. FDA issues final medical device reporting regulation. Healthc Hazard Mater Manage; 1996 Feb; 9(5):5-6. PubMed ID: 10154800 [No Abstract] [Full Text] [Related]
19. Semper fidelis--consumer protection for patients with implanted medical devices. Maisel WH N Engl J Med; 2008 Mar; 358(10):985-7. PubMed ID: 18322280 [No Abstract] [Full Text] [Related]
20. US and European postmarket clinical data requirements. Donawa M Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]